BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9871662)

  • 1. Trans-4-methyl-3-imidazoyl pyrrolidine as a potent, highly selective histamine H3 receptor agonist in vivo.
    Shih NY; Aslanian R; Lupo AT; Orlando S; Piwinski JJ; Green MJ; Ganguly AK; West R; Tozzi S; Kreutner W; Hey JA
    Bioorg Med Chem Lett; 1998 Feb; 8(3):243-8. PubMed ID: 9871662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the pharmacology of the novel histamine H3 receptor agonist Sch 50971.
    Hey JA; Aslanian R; Bolser DC; Chapman RW; Egan RW; Rizzo CA; Shih NY; Fernandez X; McLeod RL; West R; Kreutner W
    Arzneimittelforschung; 1998 Sep; 48(9):881-8. PubMed ID: 9793613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel pyrrolidine analog of histamine as a potent, highly selective histamine H3 receptor agonist.
    Shih NY; Lupo AT; Aslanian R; Orlando S; Piwinski JJ; Green MJ; Ganguly AK; Clark MA; Tozzi S; Kreutner W
    J Med Chem; 1995 May; 38(10):1593-9. PubMed ID: 7752184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sch 50971, an orally active histamine H3 receptor agonist, inhibits central neurogenic vascular inflammation and produces sedation in the guinea pig.
    McLeod RL; Aslanian R; del Prado M; Duffy R; Egan RW; Kreutner W; McQuade R; Hey JA
    J Pharmacol Exp Ther; 1998 Oct; 287(1):43-50. PubMed ID: 9765320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-substituted piperidinyl alkyl imidazoles: discovery of methimepip as a potent and selective histamine H3 receptor agonist.
    Kitbunnadaj R; Hashimoto T; Poli E; Zuiderveld OP; Menozzi A; Hidaka R; de Esch IJ; Bakker RA; Menge WM; Yamatodani A; Coruzzi G; Timmerman H; Leurs R
    J Med Chem; 2005 Mar; 48(6):2100-7. PubMed ID: 15771452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the histamine receptors in the guinea-pig lung: evidence for relaxant histamine H3 receptors in the trachea.
    Cardell LO; Edvinsson L
    Br J Pharmacol; 1994 Feb; 111(2):445-54. PubMed ID: 7911715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the novel histamine H3-receptor antagonist N-(3,5-dichlorophenyl)-N'-[[4-(1H-imidazol-4-ylmethyl)phenyl]-methyl]-urea (SCH 79687).
    McLeod RL; Rizzo CA; West RE; Aslanian R; McCormick K; Bryant M; Hsieh Y; Korfmacher W; Mingo GG; Varty L; Williams SM; Shih NY; Egan RW; Hey JA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1037-44. PubMed ID: 12649305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of 4-(1H-imidazol-4(5)-ylmethyl)pyridine (immethridine) as a novel, potent, and highly selective histamine H(3) receptor agonist.
    Kitbunnadaj R; Zuiderveld OP; Christophe B; Hulscher S; Menge WM; Gelens E; Snip E; Bakker RA; Celanire S; Gillard M; Talaga P; Timmerman H; Leurs R
    J Med Chem; 2004 May; 47(10):2414-7. PubMed ID: 15115383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties.
    Esbenshade TA; Fox GB; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan L; Wetter J; Marsh K; Bennani YL; Cowart MD; Sullivan JP; Hancock AA
    J Pharmacol Exp Ther; 2005 Apr; 313(1):165-75. PubMed ID: 15608078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological characterization of histamine H3 receptors in human saphenous vein and guinea pig ileum.
    Valentine AF; Rizzo CA; Rivelli MA; Hey JA
    Eur J Pharmacol; 1999 Jan; 366(1):73-8. PubMed ID: 10064154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of histamine H3-receptors in guinea-pig ileum with H3-selective ligands.
    Hew RW; Hodgkinson CR; Hill SJ
    Br J Pharmacol; 1990 Nov; 101(3):621-4. PubMed ID: 1963802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological characterization of H3 receptor antagonists with imidazole, thioimidazole and thioimidazoline polar groups in the side chain.
    Barocelli E; Ballabeni V; Chiavarini M; Bertoni S; Mor M; Plazzi PV; Bordi F; Impicciatore M
    Inflamm Res; 2000 Apr; 49 Suppl 1():S62-3. PubMed ID: 10864424
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of the receptor selectivity of the H3 receptor antagonists, iodophenpropit and thioperamide: an interaction with the 5-HT3 receptor revealed.
    Leurs R; Tulp MT; Menge WM; Adolfs MJ; Zuiderveld OP; Timmerman H
    Br J Pharmacol; 1995 Oct; 116(4):2315-21. PubMed ID: 8564266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unexpected partial H1-receptor agonism of imidazole-type histamine H3-receptor antagonists lacking a basic side chain.
    Sadek B; Elz S; Pertz HH; Stark H; Schunack W
    Inflamm Res; 2004 Aug; 53 Suppl 2():S109-15. PubMed ID: 15338060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of chiral N-alkylcarbamates as new leads for potent and selective H3-receptor antagonists: synthesis, capillary electrophoresis, and in vitro and oral in vivo activity.
    Sasse A; Kiec-Kononowicz K; Stark H; Motyl M; Reidemeister S; Ganellin CR; Ligneau X; Schwartz JC; Schunack W
    J Med Chem; 1999 Feb; 42(4):593-600. PubMed ID: 10052966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and structure-activity relationships of novel non-imidazole histamine H(3) receptor antagonists.
    Linney ID; Buck IM; Harper EA; Kalindjian SB; Pether MJ; Shankley NP; Watt GF; Wright PT
    J Med Chem; 2000 Jun; 43(12):2362-70. PubMed ID: 10882362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and pharmacological characterization of a series of new 1H-4-substituted-imidazoyl histamine H3 receptor ligands.
    Yates SL; Phillips JG; Gregory R; Pawlowski GP; Fadnis L; Khan MA; Ali SM; Tedford CE
    J Pharmacol Exp Ther; 1999 May; 289(2):1151-9. PubMed ID: 10215699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of histamine-H3 receptors controlling non-adrenergic non-cholinergic contractions of the guinea-pig isolated ileum.
    Taylor SJ; Kilpatrick GJ
    Br J Pharmacol; 1992 Mar; 105(3):667-74. PubMed ID: 1352720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High antagonist potency of GT-2227 and GT-2331, new histamine H3 receptor antagonists, in two functional models.
    Tedford CE; Hoffmann M; Seyedi N; Maruyama R; Levi R; Yates SL; Ali SM; Phillips JG
    Eur J Pharmacol; 1998 Jun; 351(3):307-11. PubMed ID: 9721022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of evidence for histamine H3 receptor function in rat ileum and human colon.
    Hemedah M; Loiacono R; Coupar IM; Mitchelson FJ
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):133-8. PubMed ID: 11218065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.